RxDoctor Payments Data

Angela Kapalko

Medical · Philadelphia, PANPI 1730376872

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $76,745 of the $123,007 with a category attached, or 62.4%. 18 manufacturers reported payments, led by Viiv Healthcare Company at 51.3% of the total. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$123,007in general payments, 2019–2025

Across 455 payments — averaging $270.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$63K
  • Gilead$50K
  • Theratechnologies Inc.$5K
  • Alkermes, Inc.$3K
  • Janssen Products, LP$930
  • Merck$707
  • plus $897 from 12 others

What the payments were for

  • Consulting fees$18,43015%
  • Speaking & faculty fees$76,74562%
  • Travel & lodging$17,47114%
  • Food & beverage$10,2118%
  • Education$1500%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$123,007 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala61$229,461
DovatoDolutegravir Sodium/Lamivudine33$98,119
TivicayDolutegravir Sodium12$22,647
MounjaroTirzepatide17$17,455
VivitrolNaltrexone Microspheres11$16,593
OzempicSemaglutide13$12,240
JardianceEmpagliflozin12$7,229
EliquisApixaban11$6,902
Albuterol Sulfate HfaAlbuterol Sulfate22$557
ValacyclovirValacyclovir Hcl15$430
Omega-3 Acid Ethyl Esters12$360
Gabapentin28$301
Amlodipine Besylate27$125
Carvedilol17$122
Atorvastatin Calcium30$116

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$49,789$229,46161 claims
Viiv Healthcare CompanyDovato, Tivicay$63,143$120,76645 claims
Lilly USA, LLCMounjaro$33$17,45517 claims
Alkermes, Inc.Vivitrol$2,985$16,59311 claims
Novo NordiskOzempic$20$12,24013 claims
Boehringer IngelheimJardiance$48$7,22912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →